Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Summary
The purpose of this observational study is to evaluate the safety and efficacy of Adebrelimab Injection in extensive-stage small cell lung cancer (ES-SCLC) under real-world conditions. Specifically, the study aims to assess the treatment of Adebrelimab Injection across various subgroups of ES-SCLC patients. The goal is to provide information on treatment patterns and effectiveness in real-life settings, explore potential predictive or prognostic biomarkers, and preliminarily evaluate the pharmacoeconomic indicators of Adebrelimab Injection treatment for extensive-stage small cell lung cancer.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2024-08-01
Completion Date
2026-09-01
Last Updated
2024-07-31
Healthy Volunteers
Not specified
Interventions
First-line Adebrelimab regiment for advanced stage ES-SCLC
First-line Adebrelimab in any regiment for advanced stage ES-SCLC
Second-line and beyond Adebrelimab regiment for advanced stage ES-SCLC
Second-line and beyond Adebrelimab in any regiment for advanced stage ES-SCLC